NL300391I2 - Een verzwakt Japanse encefalitus-virus aangepast aan Vero-cellen en een Japanse encefalitis vaccin - Google Patents
Een verzwakt Japanse encefalitus-virus aangepast aan Vero-cellen en een Japanse encefalitis vaccinInfo
- Publication number
- NL300391I2 NL300391I2 NL300391C NL300391C NL300391I2 NL 300391 I2 NL300391 I2 NL 300391I2 NL 300391 C NL300391 C NL 300391C NL 300391 C NL300391 C NL 300391C NL 300391 I2 NL300391 I2 NL 300391I2
- Authority
- NL
- Netherlands
- Prior art keywords
- japanese encephalitis
- weakened
- vero cells
- vaccine
- virus adapted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24151—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR19970042002 | 1997-08-28 | ||
| KR19970042001 | 1997-08-28 | ||
| PCT/KR1998/000259 WO1999011762A1 (en) | 1997-08-28 | 1998-08-25 | An attenuated japanese encephalitis virus adapted to vero cell and a japanese encephalitis vaccine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NL300391I1 NL300391I1 (nl) | 2009-08-03 |
| NL300391I2 true NL300391I2 (nl) | 2009-11-02 |
Family
ID=26633032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL300391C NL300391I2 (nl) | 1997-08-28 | 2009-06-10 | Een verzwakt Japanse encefalitus-virus aangepast aan Vero-cellen en een Japanse encefalitis vaccin |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6309650B1 (https=) |
| EP (2) | EP1025209B1 (https=) |
| JP (1) | JP4161017B2 (https=) |
| KR (1) | KR100314404B1 (https=) |
| CN (1) | CN1142271C (https=) |
| AU (1) | AU748730B2 (https=) |
| CA (1) | CA2301000C (https=) |
| DE (2) | DE69837211T2 (https=) |
| DK (2) | DK1025209T3 (https=) |
| ES (2) | ES2382946T3 (https=) |
| FR (1) | FR09C0037I2 (https=) |
| MY (1) | MY129773A (https=) |
| NL (1) | NL300391I2 (https=) |
| NZ (1) | NZ503522A (https=) |
| WO (1) | WO1999011762A1 (https=) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000083657A (ja) * | 1998-07-13 | 2000-03-28 | Chemo Sero Therapeut Res Inst | 日本脳炎ウイルスワクチン |
| US6841374B1 (en) | 1998-10-05 | 2005-01-11 | Research Foundation For Microbial Diseases Of Osaka University | Enhanced immunogen for inactivated vaccine for infection with Japanese encephalitis viruses and process for producing the same |
| DK2251419T3 (da) * | 1999-04-22 | 2012-07-02 | Us Agriculture | Porcint reproduktions- og respirations-syndrom-vaccine baseret på isolat JA-142 |
| WO2001076624A1 (en) * | 2000-04-07 | 2001-10-18 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Inactivated japanese b encephalitis vaccine and process for producing the same |
| WO2003002069A2 (en) * | 2001-06-29 | 2003-01-09 | Becton, Dickinson And Company | Intradermal delivery of vaccines and gene therapeutic agents via microcannula |
| JP2007068401A (ja) * | 2003-08-07 | 2007-03-22 | Chemo Sero Therapeut Res Inst | 西ナイルウイルスワクチン |
| NZ548495A (en) * | 2004-02-23 | 2009-05-31 | Crucell Holland Bv | Virus purification methods |
| CN100340596C (zh) * | 2004-05-20 | 2007-10-03 | 佛山市顺德区汉达精密电子科技有限公司 | 回收聚碳酸酯/丙烯腈－丁二烯－苯乙烯共聚物及其回收方法 |
| DK1869171T4 (en) * | 2005-04-11 | 2016-01-18 | Crucell Holland Bv | Virus cleaning using ultrafiltration |
| CA2676775A1 (en) * | 2007-01-31 | 2008-09-25 | Sanofi Pasteur Biologics Co. | Flavivirus vaccine vector against influenza virus |
| KR20160003301A (ko) * | 2007-12-26 | 2016-01-08 | 기타사토 다이이치 산쿄 백신 가부시키가이샤 | 안정하게 장기간 보존할 수 있는 일본뇌염 백신의 제조방법 및 그 백신의 용도 |
| EP2298344B1 (en) * | 2008-06-04 | 2016-08-17 | The Chemo-Sero-Therapeutic Research Institute | Use of inactivated japanese encephalitis virus particle as adjuvant |
| KR101622738B1 (ko) * | 2008-07-30 | 2016-05-19 | 히사미쓰 세이야꾸 가부시키가이샤 | 마이크로니들 디바이스 및 마이크로니들 디바이스에 의한 일본 뇌염 바이러스 항원의 주효성을 상승시키는 방법 |
| WO2010137036A2 (en) * | 2009-05-25 | 2010-12-02 | Panacea Biotec Ltd | Novel japanese encephalitis vaccine and method of manufacturing the same |
| KR101144993B1 (ko) * | 2009-06-18 | 2012-06-27 | 대한민국 | 돼지 일본뇌염 바이러스의 고농축 혈구응집용 항원 |
| ES2647882T3 (es) | 2011-12-06 | 2017-12-27 | Valneva Austria Gmbh | Compuestos de aluminio para su uso en productos terapéuticos y vacunas |
| US9895437B2 (en) | 2012-04-18 | 2018-02-20 | Valneva Austria Gmbh | Aluminum compounds for use in therapeutics and vaccines |
| RU2706693C2 (ru) * | 2013-09-14 | 2019-11-20 | Бхарат Байотек Интернэшнл Лимитед | Вирусная вакцина и способы ее производства |
| CN105695424B (zh) * | 2015-04-01 | 2019-06-14 | 中国食品药品检定研究院 | 乙型脑炎减毒活疫苗株sa14-14-2在人二倍体细胞2bs上的适应株及其疫苗 |
| EP3393509B1 (en) | 2015-12-23 | 2024-02-28 | Valneva SE | Virus purification |
| EP3403671B1 (en) * | 2016-01-15 | 2023-06-07 | KM Biologics Co., Ltd. | Vaccine containing immobilized virus particles |
| WO2017210215A1 (en) | 2016-05-31 | 2017-12-07 | The Government Of The United States Of America As Represented By The Secretary Of The Army | Zika virus vaccine and methods of production |
| EP3684404A1 (en) | 2017-09-21 | 2020-07-29 | Valneva SE | Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus chikv-delta5nsp3 |
| MX2020004543A (es) | 2017-11-03 | 2020-09-18 | Takeda Vaccines Inc | Vacunas contra el zika, composiciones inmunogenicas y metodos que las utilizan. |
| CN116983398A (zh) | 2017-11-30 | 2023-11-03 | 武田疫苗股份有限公司 | 寨卡疫苗和免疫原性组合物以及其使用方法 |
| CN110684747B (zh) | 2018-07-06 | 2024-05-24 | 厦门大学 | 灭活及保存呼吸道合胞病毒的方法 |
| WO2020045368A1 (ja) * | 2018-08-27 | 2020-03-05 | マイキャン・テクノロジーズ株式会社 | 不死化単球細胞および誘導細胞を用いた抗感染症薬，ワクチンなどの評価方法 |
| EP3895729A1 (en) | 2020-03-01 | 2021-10-20 | Valneva Austria GmbH | Cpg-adjuvanted sars-cov-2 virus vaccine |
| AU2021229710A1 (en) | 2020-03-01 | 2022-10-06 | Dynavax Technologies Corporation | CPG-adjuvanted SARS-CoV-2 virus vaccine |
| WO2021178306A1 (en) | 2020-03-01 | 2021-09-10 | Dynavax Technologies Corporation | Coronavirus vaccines comprising a tlr9 agonist |
| EP4114456A1 (en) | 2020-03-06 | 2023-01-11 | The Colorado State University Research Foundation | Production of vaccines comprising inactivated sars-cov-2 viral particles |
| TW202203967A (zh) | 2020-04-06 | 2022-02-01 | 奧地利商瓦爾尼瓦奧地利有限責任公司 | 不活化ＳＡＲＳ—ＣｏＶ—２病毒疫苗 |
| WO2023148256A1 (en) | 2022-02-02 | 2023-08-10 | Valneva Austria Gmbh | Inactivated sars-cov-2 virus vaccine |
| EP4428231A4 (en) * | 2022-04-20 | 2025-11-19 | Korea Nat Institute Of Health | GENOTYPE 5 OF HIGH-TIRES JAPANESE ENCEPHALITIS VIRUS AND ITS USE |
| EP4652265A1 (en) | 2023-01-18 | 2025-11-26 | Valneva Austria GmbH | Process for virus production in a bioreactor |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2704258B2 (ja) * | 1987-10-31 | 1998-01-26 | 日本臓器製薬株式会社 | 組み換えワクチニアウイルス |
| GB8821656D0 (en) * | 1988-09-15 | 1988-10-12 | Health Lab Service Board | Pharmaceutical compositions for eliciting immunostimulant effect |
| JPH085803B2 (ja) * | 1988-11-10 | 1996-01-24 | 武田薬品工業株式会社 | 日本脳炎ワクチンの製造法 |
| EP0562136A1 (en) | 1992-03-24 | 1993-09-29 | Division Of Microbiology, Kyoto Biken Laboratories, Inc. | Live vaccine to getah virus infectious disease, and trivalent live vaccine to Japanese encephalitis virus, porcine parvovirus and getah virus infectious diseases |
| US6010894A (en) * | 1997-06-13 | 2000-01-04 | Research Development Foundation | Method of screening for attenuating viruses |
-
1998
- 1998-08-25 EP EP98941885A patent/EP1025209B1/en not_active Expired - Lifetime
- 1998-08-25 DK DK98941885T patent/DK1025209T3/da active
- 1998-08-25 ES ES05014317T patent/ES2382946T3/es not_active Expired - Lifetime
- 1998-08-25 DE DE69837211T patent/DE69837211T2/de not_active Expired - Lifetime
- 1998-08-25 JP JP2000508774A patent/JP4161017B2/ja not_active Expired - Lifetime
- 1998-08-25 CN CNB988097974A patent/CN1142271C/zh not_active Expired - Lifetime
- 1998-08-25 ES ES98941885T patent/ES2281929T3/es not_active Expired - Lifetime
- 1998-08-25 CA CA002301000A patent/CA2301000C/en not_active Expired - Lifetime
- 1998-08-25 NZ NZ503522A patent/NZ503522A/en not_active IP Right Cessation
- 1998-08-25 EP EP05014317A patent/EP1604685B1/en not_active Expired - Lifetime
- 1998-08-25 DE DE122009000037C patent/DE122009000037I2/de active Active
- 1998-08-25 WO PCT/KR1998/000259 patent/WO1999011762A1/en not_active Ceased
- 1998-08-25 DK DK05014317.1T patent/DK1604685T3/da active
- 1998-08-25 AU AU90047/98A patent/AU748730B2/en not_active Expired
- 1998-08-25 US US09/486,392 patent/US6309650B1/en not_active Expired - Lifetime
- 1998-08-26 MY MYPI98003899A patent/MY129773A/en unknown
- 1998-08-27 KR KR1019980035007A patent/KR100314404B1/ko not_active Expired - Fee Related
-
2009
- 2009-06-10 NL NL300391C patent/NL300391I2/nl unknown
- 2009-08-14 FR FR09C0037C patent/FR09C0037I2/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU748730B2 (en) | 2002-06-13 |
| DE122009000037I1 (de) | 2009-11-05 |
| US6309650B1 (en) | 2001-10-30 |
| KR100314404B1 (ko) | 2002-10-12 |
| EP1604685A2 (en) | 2005-12-14 |
| EP1025209A1 (en) | 2000-08-09 |
| FR09C0037I2 (fr) | 2021-11-05 |
| MY129773A (en) | 2007-04-30 |
| EP1604685A3 (en) | 2006-07-05 |
| JP4161017B2 (ja) | 2008-10-08 |
| EP1604685B1 (en) | 2012-02-22 |
| FR09C0037I1 (https=) | 2009-09-25 |
| CA2301000C (en) | 2003-07-08 |
| DE69837211T2 (de) | 2007-12-06 |
| CN1272879A (zh) | 2000-11-08 |
| DK1604685T3 (da) | 2012-06-18 |
| CN1142271C (zh) | 2004-03-17 |
| ES2281929T3 (es) | 2007-10-01 |
| AU9004798A (en) | 1999-03-22 |
| JP2001514844A (ja) | 2001-09-18 |
| DE69837211D1 (de) | 2007-04-12 |
| WO1999011762A1 (en) | 1999-03-11 |
| EP1025209B1 (en) | 2007-02-28 |
| DK1025209T3 (da) | 2007-06-25 |
| DE122009000037I2 (de) | 2011-06-16 |
| KR19990023955A (ko) | 1999-03-25 |
| CA2301000A1 (en) | 1999-03-11 |
| NZ503522A (en) | 2001-06-29 |
| NL300391I1 (nl) | 2009-08-03 |
| ES2382946T3 (es) | 2012-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL300391I2 (nl) | Een verzwakt Japanse encefalitus-virus aangepast aan Vero-cellen en een Japanse encefalitis vaccin | |
| DE69800383D1 (de) | Influenza Vaccine | |
| CY2012033I2 (el) | Φαρμακευτικα σκευασματα σε μορφη αερολυματος | |
| DE69630044D1 (de) | Viren inaktivierende umhüllungen | |
| NL300379I2 (nl) | Bepaalde 5-alkyl-2-arylaminofenylazijnzuren en derivaten daarvan | |
| NO976060D0 (no) | Vaksiner mot hepatitt C | |
| DE60018074D1 (de) | Faltbarer einweg-dosieraerosolabstandshalter und verfahren dazu | |
| ID22873A (id) | Senyawa-senyawa heterosiklik dan pemakaiannya untuk menginhibisi b-amyloid peptida | |
| NO20004104L (no) | Preparater omfattende virus og fremgangsmater for konsentrering av viruspreparater | |
| IS5433A (is) | Sýklískar amínafleiður og notkun þeirra sem lyf | |
| GB9811433D0 (en) | Virus vaccine | |
| DE69820660D1 (de) | Träger zum halten von orthodontischen brackets | |
| ID17506A (id) | Benda absorben dan metode untuk memproduksinya | |
| EP1037974A4 (en) | TRUNCATED PROTEIN OF HEPATITIS C VIRUS NS5B AND RELATED METHODS OF IDENTIFYING ANTIVIRAL COMPOUNDS | |
| HUP0104881A3 (en) | Method to produce inactivated w/o emulsion adjuvated vaccines | |
| IS5777A (is) | Bóluefnisvakið lifrarbólgu B veiruafbrigði og notkun þess | |
| DE69826593D1 (de) | Neospora Impstoff | |
| GB9713979D0 (en) | Method for attaching peg to macromolecules | |
| EP0769952A4 (en) | VACCINE AGAINST THE INFECTIOUS CHICKEN ANEMIA VIRUS | |
| ATE240392T1 (de) | Spezifische oligonukleotide fuer hepatitis c- virus | |
| PT841943E (pt) | Virus herpeticos avirulentos uteis como agentes tumoricidas e vacinas | |
| HU9702540D0 (en) | Carrying matherial for virus vaccine administered in intranasal way and virus vaccine itself | |
| HU0400424D0 (en) | Hepatitis virus vaccines | |
| FR2789764B1 (fr) | Analyseur d'impulsion de rayonnement unique et breve | |
| KR970050438U (ko) | 피엘엘과 디엘엘을 이용한 클럭발생 장치 |